NCT05178823

Brief Summary

Objectives: To reduce the microbial level in the aerosol created during dental procedures is essential in avoiding infections. The aim of this study was to examine the change of Streptococcus mutans (S. mutans) and the total bacterial load in human saliva in vivo after a single rinse with different mouthwashes. Material and methods: One mL unstimulated saliva was collected from volunteers with poor oral hygiene at baseline and 5 min after a one-min rinsing with Solumium Oral® (hyper-pure 0.0015% chlorine dioxide; ClO2), Listerine Total Care®, Corsodyl® (0.2% chlorhexidine-digluconate; CHX), or BioGate Si\*CLEAN for bacterial investigation. In a second study volunteers rinsed with 0.003% ClO2 or CHX for one-min and saliva was collected at baseline, after 5 and 90 min. After plating the total plate and S. mutans colony numbers were determined.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
171

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jun 2017

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

December 17, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 5, 2022

Completed
Last Updated

February 24, 2022

Status Verified

February 1, 2022

Enrollment Period

2.3 years

First QC Date

December 17, 2021

Last Update Submit

February 23, 2022

Conditions

Keywords

single rinsemouthwashchlorine dioxideS. mutans

Outcome Measures

Primary Outcomes (1)

  • Salivary bacterial CFU/mL

    Salivary bacterial CFU/mL

    1 or 90 min after rinsing

Study Arms (4)

Corsodyl

ACTIVE COMPARATOR

Chlorhexidine

Drug: Chlorhexidine mouthwash

Solumium Oral

EXPERIMENTAL

Chlorine dioxide

Drug: Chlorhexidine mouthwash

Listerine Total Care

EXPERIMENTAL

Essential oils, sodium fluoride, zinc chloride

Drug: Chlorhexidine mouthwash

BioGate Si*CLEAN

EXPERIMENTAL

Microsilver

Drug: Chlorhexidine mouthwash

Interventions

Comparison of oral rinses

Also known as: chlorine dioxide, essential oils, sodium fluoride, zinc chloride, microsilver
BioGate Si*CLEANCorsodylListerine Total CareSolumium Oral

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • DMF≥10,
  • minimum 5 active caries
  • PSR≥2

You may not qualify if:

  • smoking,
  • a history of antibiotic, or probiotic use 3 months prior to sampling
  • known allergy to any of the ingredients of mouthwashes being tested

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Semmelweis University

Budapest, 1088, Hungary

Location

Related Publications (1)

  • Herczegh A, Gyurkovics M, Agababyan H, Ghidan A, Lohinai Z. Comparing the efficacy of hyper-pure chlorine-dioxide with other oral antiseptics on oral pathogen microorganisms and biofilm in vitro. Acta Microbiol Immunol Hung. 2013 Sep;60(3):359-73. doi: 10.1556/AMicr.60.2013.3.10.

MeSH Terms

Conditions

Gingival Diseases

Interventions

chlorine dioxideOils, VolatileSodium Fluoridezinc chloride

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

OilsLipidsFluoridesHydrofluoric AcidFluorine CompoundsInorganic ChemicalsSodium CompoundsCariostatic AgentsBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Zsolt Lohinai, PHD

    Semmelweis University, Department of Conservative Dentistry

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2021

First Posted

January 5, 2022

Study Start

June 1, 2017

Primary Completion

September 1, 2019

Study Completion

September 1, 2020

Last Updated

February 24, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations